SA
WST icon

SpiderRock Advisors’s West Pharmaceutical WST Stock Holding History

SpiderRock Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$1.19K – 170
2022
Q4 		– Hold
0
– – – 57
2022
Q3 		– Hold
0
– – – 45
2022
Q2 		– Hold
0
– – – 36
2022
Q1 		– Hold
0
– – – 40

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SpiderRock Advisors's WST Position: Q3 2024 in Review

SpiderRock Advisors increased its West Pharmaceutical (WST) stake by 26% in Q3 2024, buying an estimated $355K and bringing the position to 5,589 shares worth $1.68M. The position accounts for 0.03% of the portfolio, ranked #355.

SpiderRock Advisors first reported a position in WST in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.75M in Q1 2024. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • SpiderRock Advisors held 5,589 shares of West Pharmaceutical worth $1.68M as of Q3 2024.
  • SpiderRock Advisors bought 1,160 West Pharmaceutical shares in Q3 2024, an estimated $355K.
  • West Pharmaceutical made up 0.03% of SpiderRock Advisors's portfolio in Q3 2024, its #355 holding.
  • SpiderRock Advisors first reported a position in West Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
  • SpiderRock Advisors's West Pharmaceutical position peaked at $1.75M in Q1 2024.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.